Chances are your approach to sun protection has changed in recent years. Thanks to organizations like The Skin Cancer Foundation and our allies in the media who help spread our message, public awareness about skin cancer is at an all-time high. I was struck by this shift as I read through magazines that once promoted tanning oils and are now filling their pages with boundless sunscreen options and cautioning against skin cancer.
News & Research
You need sun protection as much as you need vitamin D. You can have both, without skin damage or nutritional deficiency. A dermatologist tells you how.
According to a new study, melanoma patients with a history of smoking are more likely to die from the disease than patients who do not smoke. The study, funded by Cancer Research UK and published in the journal Cancer Research, found that melanoma patients with a history of smoking cigarettes are 40 percent less likely to survive the disease than those who have never smoked.
Why do some people seem to be resistant to skin cancer, while many of us (who regularly visit SkinCancer.org) seem prone to it? Turns out there’s a gene that’s at least partially responsible, according to a 2016 study.
We saw the FDA approve a groundbreaking drug, companies debut new technology to help increase our awareness of dangerous ultraviolet (UV) rays and lawmakers pass indoor tanning legislation.
You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.
Firefighters risk their lives running into burning buildings, but the menace doesn’t come just from the fire. They may face an increased risk for developing melanoma, the most dangerous of the three most common types of skin cancer.